Connect with us

Mental health

Oncology Nutrition Market to Reach $4.87 Billion by 2033, Growing at 8.9% CAGR

Published

on

Oncology Nutrition Market to Reach $4.87 Billion by 2033, Growing at 8.9% CAGR

Oncology Nutrition Market

The Oncology Nutrition Market is estimated to experience significant growth, and its value is expected to rise from USD 2.07 billion by 2023 to USD 4.87 billion by 2033to reflect a Average CAGR of 8.9% during the forecast. The increasing demand for nutrition in oncology is driven by the growing awareness of the important role that nutritional therapy plays in cancer care.

Medical nutrition therapy (MNT) is important for cancer patients, as it helps improve physical function, aids recovery during and after cancer treatment, and improves quality of life. in general. Since cancer treatment often leads to side effects such as decreased appetite and malabsorption, the importance of nutritional strategies is becoming increasingly prominent. This has led to an increase in the adoption of oncology nutritional products that support better treatment tolerance and improve patient outcomes.

In addition, increased focus on nutritional assessment and evaluation helps identify patients at high risk of malnutrition, which is common among cancer patients. This trend encourages healthcare providers to incorporate oncology nutrition into the overall treatment strategy, furthering market growth.

Market Highlights

Advertisement
  • The Importance of Medical Nutrition Therapy: Clinical nutrition therapy plays an important role in improving physical fitness, supporting patients during cancer treatment, and improving overall quality of life. This treatment is very important as patients often have a reduced tolerance to cancer treatment, which drives the demand for special oncology nutritional products.
  • Nutritional Analysis and Analysis: It is important to identify people at risk of malnutrition through nutritional screening, as many cancer patients face malnutrition that can affect their treatment outcomes.

Growth Drivers

  • The increasing incidence of Cancer: The prevalence of cancer worldwide requires effective nutritional support for patients undergoing treatment.
  • Focus on Special Nutrition: There is a growing awareness of the need for nutritional solutions to address the unique challenges faced by cancer patients, including those undergoing chemotherapy and radiation therapy.
  • Advances in Technology+

Market Trends

  • The oncology nutrition market is expected to benefit from increased research and development activities, leading to the launch of new products aimed at improving patient outcomes.
  • North America is expected to hold the largest market share, driven by advanced healthcare facilities and high levels of awareness about the importance of nutrition in cancer care.

Problems

Despite the positive outlook, challenges such as high costs associated with oncology nutritional products may hinder widespread adoption among patients. continuous improvement in product development.

Request a Sample Copy Now: https://www.fmisamplereport.com/sample/rep-gb-14411

Important information:

  • The Oncology Nutrition market is expected to grow in the long term CAGR of 8.9%.the arrival USD 4.87 billion in 2033.
  • The increasing proportion of the medical nutrition therapy in cancer treatment is a key driver of market growth.
  • Screening and nutritional assessment is still needed to identify patients at risk, increasing the demand for oncology nutritional products.
  • Nutritional solutions improve the outcome of cancer treatment, help patients tolerate treatments better and improve their quality of life.

With the growing demand for supportive care in cancer treatment, the oncology nutrition market is in the process of continuous growth, offering new solutions that improve patient recovery and health during the journey of see cancer.

Oncology Nutrition Market Analysis

  • Development of basic formulas and product innovation based on non-GMO formulas.
  • Change in emphasis from parenteral to nutritional.
  • The incidence of cancer is increasing, especially the increase in patients receiving treatment for malnutrition.
  • The growing demand for nutrition in the home care industry.
  • Improving the quality of clinical research on nutritional interventions.

Competitive Landscape of Oncology Nutrition Market

The introduction of new products and advanced scientific technologies are key strategies adopted by prominent players in the oncology nutrition market. Health care organizations are changing due to new research and increased public knowledge about the benefits of nutrition in oncology. Clinical nutritionists and oncologists work closely to improve nutrition and oncology treatment within the field of nutrition oncology.

Advertisement

The presence of competitors, new product launches, and interactions related to the industry under consideration all contribute to market growth. According to the report, Esperer has started its nutrition development center in Hyderabad in 2020. The Hyderabad center is expected to have several integrated processes, such as research rooms and product development centers, which with a dedicated laboratory for testing sensory, packaging, and taste components.

The world’s leading companies for oncology nutrition are focused on obtaining regulatory approval, developing advanced products, developing new products, and collaborating and acquiring other businesses. . The global oncology nutrition market is estimated to grow due to these strategies of leading players. The following are a few expansion strategies used by companies in the oncology nutrition market:

  • To increase its presence in medical nutrition, Nestle acquired Allergan’s business in January 2020.
  • Smartfish AS and B. Braun worked together to launch Remune, a pharmaceutical nutrition solution, in September 2019. In 2019 and 2020, B. Braun launched Remune in more than 20 countries. many others in Europe, Asia and South America.
  • Ina, the smart nutrition assistant, was launched by CancerCare in partnership with Savor Health in 2019. Ina provides evidence-based nutrition counseling to help cancer patients eat well and stay nourished. during treatment.
  • A three-chamber bag with a unique protein-to-energy ratio called mofKabiven Nitrogen extra was introduced by Fresenius Kabi AG in 2018 in Europe.
  • The SmartPN device was introduced in October 2018 by Baxter International Inc. and the American Society for Parenteral and Enteral Nutrition (ASPEN) to reduce medical malnutrition.

Key Players in Oncology Nutrition Market

  • FMC group
  • Danone India
  • Abbott
  • Vinegar
  • B. Braun Melsungen AG
  • Baxter
  • Fresenius Cabbage AG
  • Global Health Products, Inc.
  • Hormel Foods Corporation
  • Mead Johnson & Company, LLC
  • Meiji Holdings Co., Ltd
  • Nestlé SA
  • BioSig Technologies, Inc. Share Description
  • Auris Health, Inc. Share Description

Important Listed Companies

FMC Corporation; Danone India; Abbott; Aceto; B. Braun Melsungen AG; Baxter; Fresenius Kabi AG; Global Health Products, Inc.; Hormel Foods Corporation; Mead Johnson & Company, LLC; Meiji Holdings Co., Ltd.; Nestlé SA; BioSig Technologies, Inc.; Auris Health, Inc. Share Description

Main Features

By Type of Cancer:

Advertisement
  • Head and Neck Cancer
  • Stomach and Colon Cancer
  • Blood Cancer
  • Breast Cancer
  • Death Cancer
  • Other cancers

End of Use:

  • Hospitals & Clinics
  • Home Care
  • Others

By Location:

  • North America
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Author By:

Sabyasachi Ghosh (Assistant Vice President at Future Market Insights, Inc.) has over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His sense of curiosity and analysis helped him establish his career as a researcher.

Identifying the core problems customers face and designing powerful, insight-based solutions to empower them with decision-making skills comes naturally to him. His main expertise is in areas such as Market Entry and Expansion Strategy, Capability Studies, Competitive Intelligence, and Strategic Change.

Holding a degree in Microbiology, Sabyasachi has authored numerous articles and been quoted in journals, including the Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (Certified by ESOMAR, a Stevie Award recipient, and a member of the Greater New York Chamber of Commerce) provides deep insight into the driving factors that are increasing demand in the market. FMI stands as the world’s leading provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a large team of more than 400 analysts worldwide, FMI provides global, regional and local knowledge on various regions and industry trends in more than 110 countries.

Advertisement

Contact us:

Shares of Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Questions: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube


#Oncology #Nutrition #Market #Reach #Billion #Growing #CAGR

Advertisement

Mental health

The survey found that 56% say ‘alone time’ is important for mental health

Published

on

By

A new survey found that 56% say 'alone time' is important to their mental health

A new survey found that 56% say 'alone time' is important to their mental health

Finding a balance between being with her sons and finding time to rejuvenate is important to Hilary Hawk. He’s not the only one, as a new study by the Ohio State Wexner Medical Center found 56% of Americans say that time alone is very important to their mental health. Credit: Ohio State University Wexner Medical Center

Some say the holidays are the best time of the year. But for some, the busy holiday season can be the most stressful.

A new national survey of 1,000 Americans commissioned by The Ohio State University Wexner Medical Center and College of Medicine shows that 46% of Americans say they don’t get the private time they need during the holidays.

In addition, 56% of survey respondents say that it is very important for their mental health to have enough private time.

Sophie Lazarus, Ph.D., a clinical psychologist at Ohio State’s Department of Mental and Behavioral Health, says that in a world that glorifies being busy, taking a short break can be good for the mind and body. .

Advertisement

Taking a few minutes alone can reduce seasonal stress and help mental health, she said.

«Just by taking a short break, our nervous system can calm down, our mind can calm down, our body can calm down. And I think that can be important. We know that the stress of a chronic mind is not good for us,» said Lazarus.

It’s important to put yourself first, and this can be achieved by adding something simple to your routine that doesn’t require a lot of time or effort, Lasaro said.







New survey finds most Americans prefer ‘one time’ Credit: Ohio State University Wexner Medical Center

Lazarus, who focuses on mental, emotional and anxiety interventions, has a few suggestions to help stressed people stay present throughout the busy holiday season.

«Try putting your phone in a completely different room when you decide to spend some time alone, you know how hard it is to not pick it up, to attract our attention and things to come first in our lives,» said Lazarus. «Or take two or three minutes in the car before you go to pick up your kids or before you go home after work to be alone.»

Advertisement

Lazarus says to think about what works best for you when making these changes in your schedule.

«One level does not suit everyone. Flexibility and finding the best balance,» Lazaru said.

Lazarus reminds patients that it’s okay to take time alone.

«I think it’s important to remember that just because you’re putting yourself first right now doesn’t mean you’re selfish and it doesn’t mean you always make the choice to put yourself first,» Lazarus said.

Private time doesn’t have to be solitary, either.

Advertisement

«Some people might have time to go to the movies alone or go to a park where there are a lot of people, or go to a coffee shop,» Lazarus said. «It may also be the absence of having to do or interact with the community in a more direct way.»

This survey was conducted by SSRS on its Opinion Panel Omnibus platform. The SSRS Opinion Panel Omnibus is a national, bimonthly, probability-based survey. Data collection was conducted from October 4-October 7, 2024, among a sample of 1,004 respondents.

The survey was conducted online (n=974) and telephone (n=30) and was administered in English. The margin of error for the overall respondents is +/- 3.5 percentage points at the 95% level. All data in the SSRS Opinion Panel Omnibus is averaged to represent the population of US adults age 18 or older.

Provided by Ohio State University Medical Center

Advertisement

Excerpt: Survey finds 56% say ‘alone time’ is important for mental health (2024, December 3) Retrieved December 3, 2024 from https://medicalxpress.com/news/ 2024-12-survey-vital-mental-health.html

This document is subject to copyright. Except for any legitimate activity for the purpose of private study or research, no part may be reproduced without written permission. Content is provided for informational purposes only.

Advertisement


#survey #time #important #mental #health

Continue Reading

Mental health

Miss Gabriella said her husband Thomas made a «sudden» decision to ‘kill himself at his beloved parents’ home’ after suffering a negative reaction to the medication he was prescribed.

Published

on

By

Thomas Kingston (left) died of a gunshot wound to the head, a pathologist found

Prince and Princess Michael of Kent’s daughter, Lady Gabriella Kingston, said her husband died after deciding on an ‘emergency operation’ to take his own life after suffering adverse effects from the treatment he was given.

Thomas Kingston, 45, died of a gunshot wound to the head at his beloved parents’ home Cotswolds on 25 February.

Rachel married Queen Gabriella at St George’s Chapel, Windsor Castle, in 2019 with the Queen and her husband the Duke of Edinburgh among the guests.

At an inquest into her death held at Gloucestershire Coroner’s Court on Tuesday, Lady Gabriella, 43, said people needed to be warned about the effects of drugs used to treat mental health conditions or more people could die.

Advertisement

In a statement read by senior detective Katy Skerrett, Miss Gabriella said: «(The job) has been challenging for her for many years, but I strongly doubt that it would have led to her taking her own life, and it seemed to and weight.improved.

‘If there was something that was bothering him, I’m sure he would have said that he was struggling a lot.

‘The fact that he took his own life in the home of his beloved parents suggests that the decision was the result of sudden impulse.’

He said he believed her death «may have been precipitated» by an adverse reaction to medication she had started, and then stopped, weeks before her death.

Thomas Kingston (left) died of a gunshot wound to the head, a pathologist found

Thomas Kingston (left) died of a gunshot wound to the head, a pathologist found

Mr Kingston (pictured), the husband of Lady Gabriella Windsor, took his own life after an adverse reaction to the medication he was prescribed, an inquest heard.

Mr Kingston (pictured), the husband of Lady Gabriella Windsor, took his own life after an adverse reaction to the medication he was prescribed, an inquest heard.

Mr Kingston watched the race with Queen Camilla from the Royal Box at Ascot in June 2023.

Mr Kingston watched the race with Queen Camilla from the Royal Box at Ascot in June 2023.

He was initially prescribed Sertraline – an anti-depressant – and Zopiclone, a sleeping pill, by a GP at the Royal Mews Surgery – a practice used by royal staff – after complaining of difficulty sleeping after of stress at work.

Advertisement

Mr Kingston complained that this did not make him feel better and his doctor switched him from Sertraline to Citalopram, a serotonin reuptake inhibitor (SSRI) used as an anti-depressant. .

‘The lack of any evidence of propensity seems to me very likely that he had a bad reaction to the pills that caused him to kill himself,’ Lady Gabriella said.

‘I believe that anyone taking pills like these should be warned about the side effects to prevent future deaths.

‘If this can happen to Tom, it can happen to anyone.’

In the first days of his death, Mr. Kingston had stopped taking medication, and toxicology tests showed caffeine and a small amount of zopiclone in his system.

Advertisement

In his final weeks, Ms Gabriella said, her husband «seemed normal», except the morning after he first took zopiclone, which she said made him seem » want to faint».

In her statement, she described their marriage as one of ‘deep love and trust’ and said she had never expressed suicidal thoughts to herself or others.

He also said he was deeply affected by his friend’s suicide and «the negative impact it had on other people’s loved ones».

Miss Gabriella cried as she sat in the court of inquiry when her statement was read.

The couple are pictured here at the Wimbledon Tennis Championships in July 2019

The couple are pictured here at the Wimbledon Tennis Championships in July 2019

Lady Gabriella and Thomas Kingston had official photos taken on their wedding day - here with the Queen and Prince Philip sitting to their right.

Lady Gabriella and Thomas Kingston had official photos taken on their wedding day – here with the Queen and Prince Philip sitting to their right.

Thomas Kingston and court side Lady Gabriella Kingston on day two of the Wimbledon Tennis Championships last year

Thomas Kingston and court side Lady Gabriella Kingston on day two of the Wimbledon Tennis Championships last year

Mr. Kingston’s father, William Martin Kingston, wept as he described finding his son in the locked bathroom of the annexe, having used a doorknob to break the door.

Advertisement

He told the court that his son has always had a strong, unstable character, as he previously suffered from pain that left him needing help to climb the stairs.

Mr Kingston added that before his son’s death there did not appear to be a suicide investigation, and there was no will or note, describing the process as ‘very active and it was just ‘out of character’.

Closing the story, Ms Skerrett, Gloucestershire’s chief constable, said: ‘Mr Kingston took his own life with a self-inflicted gunshot wound to the head.

‘The evidence of his wife, his family and his business partner all support the lack of intent to kill himself. He was having bad side effects from the medication he had just been given.’

Dr David Healy, a psychiatrist who gave evidence at the hearing, said zopiclone could also cause anxiety, while sertraline and citalopram were both serotonin reuptake inhibitors (SSRIs), and while exactly the same.

Advertisement

Dr Healy said Mr Kingston’s complaints that sertraline continued to bother him was a sign SSRIs were ‘not working for him’, and he should not have been prescribed the same thing again.

He said the guidelines and labels for SSRIs were not clear enough about using the drug first, or what the effect would be when switching from one to another.

He said: ‘We need a clearer statement that these drugs can cause people to kill themselves who otherwise wouldn’t.

Speaking to the doctor, Martin Porter, the family’s adviser, said: ‘The family is not to blame (her doctor) Dr Naunton Morgan, he worked like a good doctor.

‘But the question is whether there is enough advice to doctors about SSRIs.’

Advertisement
Queen Camilla, King Charles III, Lady Gabriella Windsor and Thomas Kingston watch the Royal Box Race as they attend day 5 of Royal Ascot 2023.

Queen Camilla, King Charles III, Lady Gabriella Windsor and Thomas Kingston watch the Royal Box Race as they attend day 5 of Royal Ascot 2023.

Miss Gabriella paid tribute to her husband in a joint statement with his family after his death, describing him as ‘a special man who brightened the lives of all who knew him’.

They described his death as ‘a huge shock to the whole family’.

The King and Queen sent their ‘heartfelt thoughts and prayers’ to Miss Gabriella, known as Ella, and Mr Kingston’s parents and siblings.

Mr Kingston was buried in a private service on March 12.

Around 140 friends and family, including Prince William, Queen Gabriella’s parents Prince and Princess Michael of Kent, and Princess Alexandra, gathered at the Chapel Royal at St James’s Palace in London for the funeral.

Advertisement

Lady Gabriella is King’s second cousin. Both are great-grandsons of King George V.

Mr. Kingston was a director of Devonport Capital, which specializes in providing financing for companies in the economic market.

The University of Bristol graduate had also worked in Baghdad, Iraq, to ​​secure the release of hostages after joining the Foreign Office embassy.

When an inquest opened in March, Gloucestershire chief constable Katy Skerrett said Mr Kingston’s body was found in an outhouse at his parents’ home.

Mofekotsana said that Mr. Kingston was visiting his parents, and after lunch, his father went out to walk the dogs.

Advertisement

‘When he came back, Mr Kingston was not in the house’, he said, and after about 30 minutes his mother went to look for him.

‘His father forced his way into the locked building when no answer could be found.’

For free, confidential support, call Samaritans on 116 123, visit samaritans.org or visit www.thecalmzone.net/get-support.

#Gabriella #husband #Thomas #sudden #decision #kill #beloved #parents #home #suffering #negative #reaction #medication #prescribed

Advertisement
Continue Reading

Mental health

Pfizer, Eli Lilly push back as senators scrutinize drug buyer moves.

Published

on

By

Pfizer, Eli Lilly push back as senators scrutinize drug buyer moves.

You are reading the web edition of STAT’s Health Tech magazine, our guide to how technology is changing the life sciences. Sign up to receive it in your inbox every Tuesday and Thursday.

Pharma vs Congress: The latest telehealth debate

Eli Lilly and Pfizer have responded to senators who pressed them to share information about their online platforms LillyDirect and PfizerForAll, demanding to know whether the pharma giants are violating federal anti-kickback laws when they instruct patients to choose telehealth platforms that can prescribe them. drugs, my colleague Katie Palmer tells us.

Both companies asked detailed questions about the financial conditions of the Internet, as well as how patients who provide services can access the websites. Instead, they reiterated that mobile providers connected to the platform are not paid or incentivized to provide their specialty drugs.

In its response, Pfizer explained how it pays companies UpScriptHealth and Populus Health Technologies fixed monthly fees. Much of Lilly’s response did not focus on its own platform, but instead called out other telehealth companies that offer generic versions of GLP-1 drugs such as Lilly’s Tirzepatide. «Potential problems with their operation are more than worrying about the financial relationships you present in your letter,» reads its response.

Advertisement

Stay tuned for more as the latest news continues. Meanwhile, if you want to get up to speed on the broader issue, read a story Katie wrote not too long ago: How drug makers are turning telehealth into an advertising gold mine.

Using AI to design small molecule drugs is difficult

My colleague Brittany Trang has immersed herself in the world of small molecule drugs, which she compares to «an endless bag of pick-your-own frozen yogurt flavors» rather than a «boutique ice cream shop cream» provided by normal antibodies. are drugs that are classified by the amino acid alphabet.

That large number of possible compounds also means that it is difficult to show enough types of AI molecules and interactions with biologically relevant receptors for the mechanism to be more complete than has already been seen. And the models for small molecule drug design are changing, according to Pat Walters, chief data officer at Relay Therapeutics. «These models, for the most part, understand syntax, but they don’t really understand chemistry,» he says. that an organic chemist would look at and say, ‘That’s not chemically stable.’»

That hasn’t stopped new startups from raising hundreds of millions of dollars to try to push AI to suggest or design small molecule drugs. In her youth, Brittany introduces us to five of them.

In case you forgot, this is part of a new Who Should Know series that STAT started a few months ago to give you a closer look at the key influencers in modern healthcare, from research and educational courses to pharma execs, startups and investors.

Advertisement

Where exactly are we in AI drug discovery?

Speaking of AI in drug discovery, this week we heard from Bison Ventures investor Caleb Appleton who asks if it’s the beginning of the end for AI drug discovery companies – especially after a series of failed experiments ‘a great success. Appleton writes: «I’m already seeing a very waning appetite for supporting platform-based discovery companies, taking on big changes in the space and reinventing defined asset companies.» narrowly.» «There’s a long history of early failure to turn the field around too much: Investors pull back, talent looks everywhere, and times start to slip.» If you’ve had a chance to read Appleton’s First Opinion piece, let me know where you fall on the debate.

Doctors warn about environmental impact of health data

Three doctors write for STAT about the growing environmental crisis created by digitized medical data, from notes to radiographs. While that data can be useful medically and for billing, storing it creates an incredible amount of carbon; and e-waste is a public health hazard, they argue. «With the continuous growth of healthcare data in electronic health records worldwide, we as a healthcare community must take proactive measures to prevent environmental damage caused by storage more information and management,» they write. Read more.

Garth Graham of YouTube Health on health misinformation

The YouTube video platform sees itself as more than just a source of entertainment – it’s also where people go for practical information, including health-related information, according to Garth Graham, global head of health. beauty and public health. In an interview with STAT at the Milken Institute’s Future of Life Conference, Graham, a cardiologist, told my colleague Nicholas St. Fleur about how YouTube fights misinformation – and, in the line of questioning I found to be particularly important in today’s politics, how to balance removing harmful misinformation and saying that it is «free speech.» Read the Q&A here.

What we read

  • Recursion minimizes multiple functions after completing the integration, STAT
  • The founder who ended up seeking dismissal of the federal charges, Bloomberg Law
  • Despite state restrictions, Wisconsonites are getting abortions over the phone, WPR
  • You had a hysterectomy. What Did the Doctor Leave? New York Times

!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js');

fbq( 'init', '436331036555416' ); fbq( 'track', 'PageView' );

document.addEventListener( 'stat-hubspot-signup-subscribed', () => { // Successful HubSpot newsletter signup AJAX form submission. window.statGlobal.analytics.fbq( 'Lead' ); } ); } );
#Pfizer #Eli #Lilly #push #senators #scrutinize #drug #buyer #moves

Continue Reading

Trending